Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α-converting enzyme

被引:52
作者
Iwata, Michikado [1 ]
Enciso, Jorge E. Silva [1 ]
Greenberg, Barry H. [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Cardiol, San Diego, CA 92103 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2009年 / 297卷 / 05期
关键词
cleavage; soluble form; domain; SARS CORONAVIRUS; ANGIOTENSIN-CONVERTING-ENZYME-2; ACE2; RECEPTOR; PROTEIN; DOMAIN; CARBOXYPEPTIDASE; CLEAVAGE; TACE; METALLOPROTEASE; DISINTEGRIN;
D O I
10.1152/ajpcell.00036.2009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Iwata M, Silva Enciso J, Greenberg BH. Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. Am J Physiol Cell Physiol 297: C1318-C1329, 2009. First published September 16, 2009; doi:10.1152/ajpcell.00036.2009.-Angiotensin-converting enzyme 2 (ACE2) is a newly identified regulator of the renin-angiotensin system. This type I membrane-anchored protein has a catalytically active ectodomain that undergoes shedding. Tumor necrosis factor alpha-converting enzyme (TACE) has been shown to be involved in ACE2 shedding. Although pathophysiological significance of ACE2 shedding has been suggested, regulation of this process by TACE is not clearly defined. We characterized TACE-mediated constitutive ectodomain shedding of ACE2 using wild-type Chinese Hamster Ovary (WT-CHO), the TACE-mutant M2 (M2-CHO) cells, and EC-4 and EC-2 cells that are fibroblasts from wild-type and TACE-null mice, respectively. ACE2 was constitutively cleaved to release two distinct major soluble forms. The deglycosylated molecular masses of the larger (LSF) and smaller soluble form (SSF) were similar to 80 and 70 kDa, respectively. These forms had equivalent enzyme activities. Reduced shedding for the LSF from M2-CHO and EC-2 cells when compared with WT-CHO and EC-4 cells, respectively, was noted. TACE reconstitution in EC-2 cells expressing ACE2 resulted in increase in LSF but not SSF release, demonstrating a main role of TACE in LSF release and distinct regulations of release of the two soluble forms. Deletions of the juxtamembrane region of ACE2 reduced LSF release in CHO cell lines, whereas it abolished TACE-induced shedding in EC-2 cells. Analysis of TACE structural domains confirmed that the active site in the catalytic domain is essential for ACE2 shedding but that noncatalytic domains also play additional roles. These results demonstrate selective and specific regulation of constitutive shedding of ACE2 by TACE.
引用
收藏
页码:C1318 / C1329
页数:12
相关论文
共 45 条
[1]   TRANSFORMING GROWTH-FACTOR-ALPHA AND BETA-AMYLOID PRECURSOR PROTEIN SHARE A SECRETORY MECHANISM [J].
ARRIBAS, J ;
MASSAGUE, J .
JOURNAL OF CELL BIOLOGY, 1995, 128 (03) :433-441
[2]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[3]   Substrate specificity and inducibility of TACE (tumour necrosis factor α-converting enzyme) revisited:: the Ala-Val preference, and induced intrinsic activity [J].
Black, RA ;
Doedens, JR ;
Mahimkar, R ;
Johnson, R ;
Guo, L ;
Wallace, A ;
Virca, D ;
Eisenman, J ;
Slack, J ;
Castner, B ;
Sunnarborg, SW ;
Lee, DC ;
Cowling, R ;
Jin, GX ;
Charrier, K ;
Peschon, JJ ;
Paxton, R .
PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 :39-52
[4]   Tumor necrosis factor-α converting enzyme [J].
Black, RA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01) :1-5
[5]   Impaired trafficking and activation of tumor necrosis factor-α-converting enzyme in cell mutants defective in protein ectodomain shedding [J].
Borroto, A ;
Ruíz-Paz, S ;
de la Torre, TV ;
Borrell-Pagès, M ;
Merlos-Suárez, A ;
Pandiella, A ;
Blobel, CP ;
Baselga, J ;
Arribas, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25933-25939
[6]   Characterization of the cDNA and gene for mouse tumour necrosis factor α converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25 [J].
Cerretti, DP ;
Poindexter, K ;
Castner, BJ ;
Means, G ;
Copeland, NG ;
Gilbert, DJ ;
Jenkins, NA ;
Black, RA ;
Nelson, N .
CYTOKINE, 1999, 11 (08) :541-551
[7]   Angiotensin-converting enzyme 2 is an essential regulator of heart function [J].
Crackower, MA ;
Sarao, R ;
Oudit, GY ;
Yagil, C ;
Kozieradzki, I ;
Scanga, SE ;
Oliveira-dos-Santos, AJ ;
da Costa, J ;
Zhang, LY ;
Pei, Y ;
Scholey, J ;
Ferrario, CM ;
Manoukian, AS ;
Chappell, MC ;
Backx, PH ;
Yagil, Y ;
Penninger, JM .
NATURE, 2002, 417 (6891) :822-828
[8]   The active site of a zinc-dependent metalloproteinase influences the computed pKa of ligands coordinated to the catalytic zinc ion [J].
Cross, JB ;
Duca, JS ;
Kaminski, JJ ;
Madison, VS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (37) :11004-11007
[9]   Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors [J].
Dales, NA ;
Gould, AE ;
Brown, JA ;
Calderwood, EF ;
Guan, B ;
Minor, CA ;
Gavin, JM ;
Hales, P ;
Kaushik, VK ;
Stewart, M ;
Tummino, PJ ;
Vickers, CS ;
Ocain, TD ;
Patane, MA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (40) :11852-11853
[10]   ACE2: A novel therapeutic target for cardiovascular diseases [J].
Der Sarkissian, S ;
Huentelman, MJ ;
Stewart, J ;
Katovich, MJ ;
Raizada, MK .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2006, 91 (1-2) :163-198